Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer

Pathol Res Pract. 2023 Sep:249:154739. doi: 10.1016/j.prp.2023.154739. Epub 2023 Aug 4.

Abstract

Macrophages are plastic and functionally diverse, present in all tissues, and play a key role in organisms from development, homeostasis and repair, to immune responses to pathogens. They are central to many disease states and have emerged as important therapeutic targets for many diseases. Tumor-associated macrophages (TAMs) are the most abundant immune cells in the tumor microenvironment (TME) and are key factors influencing cancer progression, metastasis and tumor recurrence. TAMs can be derived from different sources and exert different pro- or anti-tumor effects based on the type, stage and immune composition of the tumor. TAMs are highly heterogeneous and diverse, and have multiple functional phenotypes. There is still a great deal of controversy regarding the relationship between TAMs and prognosis of cancer patients. In this review, we summarize the characteristics of common markers of TAMs as well as explore the prognostic role of TAMs in different cancers including lung, breast, gastric, colorectal, esophageal and ovarian cancers.

Keywords: Cancer; Maker; Prognosis; Tumor-associated macrophages.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor* / analysis
  • Humans
  • Immunosuppression Therapy
  • Neoplasms* / diagnosis
  • Neoplasms* / immunology
  • Neoplasms* / therapy
  • Prognosis
  • Tumor-Associated Macrophages* / chemistry
  • Tumor-Associated Macrophages* / drug effects
  • Tumor-Associated Macrophages* / immunology

Substances

  • Biomarkers, Tumor